Search
Copyright © 2024 ALM Global, LLC. All Rights Reserved.
Credit: K KStock/Adobe stockMedicaid spending on GLP-1 receptor agonists has skyrocketed over the past five years. Just in the past 12 months, Medicaid spending on GLP-1s specifically for obesity has reached more than $3.5 billion, according to an analysis by Real Chemistry.
A combination of increased usage and expanded state coverage is driving Medicaid spending up exponentially, reaching more than $500 million per month as of October.
Already have an account? Sign In Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Guide
Sponsored by RxBenefits
6 Essential Questions Benefits Advisors Should Ask When Tailoring Pharmacy Benefits
This discussion guide is designed to help benefits advisors quickly understand current and potential clients’ requirements to build the perfect, tailored pharmacy benefits solution.
Guide
Sponsored by Gallagher
Mistakes happen in retirement plan administration, but they can cost you time, money, and trust. This guide will help identify and resolve 401(k) errors quickly to save significant costs and maintain compliance.
Guide
Sponsored by ArmadaCare
Benefit Changes Are Hard. Complementing Is Easy!
Help clients meet new employee benefit needs even if they don’t want to make primary health insurance plan changes.
Copyright © 2024 ALM Global, LLC. All Rights Reserved.
Sign In
Sign In
